Market Analysis

Aging population provides new business opportunities for geriatric drug market

Published in Drug Law Weekly, April 25th, 2006

On January 1, 2006, millions of senior citizens in the United States became eligible for Medicare Part D drug benefits under the provisions of the Medicare Prescription Drug, Improvement and Modernization Act (Medicare Modernization Act (MMA)).

This enormous redirection of funds into the healthcare system has the potential to disrupt the status quo within the pharmaceutical industry, creating new winners and losers. Success in the geriatric drug arena will require a detailed mastery of the new rules, a nimble approach to partnering, and the ability to respond rapidly to inevitable changes in the regulations, according to Research and Markets' report, Opportunities and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2006-04-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry